ArriVent BioPharma (AVBP) Earnings Date, Estimates & Call Transcripts → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free AVBP Stock Alerts $18.35 -0.32 (-1.71%) (As of 06/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 8) -$0.70 Beat By $0.14 Consensus EPS (May. 8) -$0.84 Get ArriVent BioPharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for AVBP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAVBP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVBP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingA Wave of Creative Destruction Set to Strike June 30You have until June 30 … then all hell will begin to break loose… The White House and Goldman Sachs predict generative AI will soon replace up to 300 MILLION jobs — one in every four careers … worldwide.Click here for details. ArriVent BioPharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($1.25)($1.25)($1.25)Q2 20242($0.75)($0.64)($0.70)Q3 20242($1.22)($0.67)($0.95)Q4 20242($1.21)($0.70)($0.96)FY 20247($4.43)($3.26)($3.85)Q1 20251($0.73)($0.73)($0.73)Q2 20251($0.76)($0.76)($0.76)Q3 20251($0.79)($0.79)($0.79)Q4 20251($0.82)($0.82)($0.82)FY 20254($3.10)($3.10)($3.10)AVBP Earnings Date and InformationArriVent BioPharma last posted its quarterly earnings results on May 8th, 2024. The reported ($0.70) earnings per share for the quarter, beating analysts' consensus estimates of ($0.84) by $0.14. ArriVent BioPharma has generated $0.00 earnings per share over the last year. Earnings for ArriVent BioPharma are expected to decrease in the coming year, from ($3.07) to ($3.13) per share. ArriVent BioPharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More ArriVent BioPharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024(Estimated)------- 5/8/2024Q1 2024($0.84)($0.70)+$0.14($0.70)-- ArriVent BioPharma Earnings - Frequently Asked Questions When is ArriVent BioPharma's earnings date? ArriVent BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on AVBP's earnings history. Did ArriVent BioPharma beat their earnings estimates last quarter? In the previous quarter, ArriVent BioPharma (NASDAQ:AVBP) reported ($0.70) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.84) by $0.14. Learn more on analysts' earnings estimate vs. AVBP's actual earnings. How much profit does ArriVent BioPharma generate each year? ArriVent BioPharma (NASDAQ:AVBP) has a recorded net income of -$69.33 million. AVBP has generated $0.00 earnings per share over the last four quarters. What is ArriVent BioPharma's EPS forecast for next year? ArriVent BioPharma's earnings are expected to decrease from ($3.07) per share to ($3.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Avidity Biosciences Earnings Indivior Earnings ACADIA Pharmaceuticals Earnings Bausch Health Companies Earnings Maravai LifeSciences Earnings Rhythm Pharmaceuticals Earnings Deciphera Pharmaceuticals Earnings Arvinas Earnings Agios Pharmaceuticals Earnings Amneal Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:AVBP) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an eff...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.